192 related articles for article (PubMed ID: 32731231)
21. Olfactory neuroblastoma: a single-center experience.
König M; Osnes T; Jebsen P; Evensen JF; Meling TR
Neurosurg Rev; 2018 Jan; 41(1):323-331. PubMed ID: 28540633
[TBL] [Abstract][Full Text] [Related]
22. Primary olfactory neuroblastoma originating from the inferior meatus of the nasal cavity.
Lee JY; Kim HK
Am J Otolaryngol; 2007; 28(3):196-200. PubMed ID: 17499140
[TBL] [Abstract][Full Text] [Related]
23. [Olfactory neuroblastoma: the Hokkaido University experience].
Kano S; Furuta Y; Homma A; Oridate N; Higuchi E; Suzuki F; Nagahashi T; Sawamura Y; Fukuda S
Nihon Jibiinkoka Gakkai Kaiho; 2006 May; 109(5):433-9. PubMed ID: 16768158
[TBL] [Abstract][Full Text] [Related]
24. Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapy.
Gumpel E; Moore AS; Simpson DJ; Hoffmann KL; Taylor DP
Aust Vet J; 2017 Jul; 95(7):227-231. PubMed ID: 28653386
[TBL] [Abstract][Full Text] [Related]
25. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
26. Olfactory neuroblastoma: a case report and review of the literature.
Ghaffar S; Salahuddin I
Ear Nose Throat J; 2005 Mar; 84(3):150-2. PubMed ID: 15871582
[TBL] [Abstract][Full Text] [Related]
27. Clincopathological analysis of olfactory neuroblastoma.
Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
[TBL] [Abstract][Full Text] [Related]
28. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
29. [Olfactory esthesioneuromas].
Martel J; Darrouzet V; Duclos JY; Bébéar JP; Stoll D
Rev Laryngol Otol Rhinol (Bord); 2000; 121(4):227-36. PubMed ID: 11233705
[TBL] [Abstract][Full Text] [Related]
30. [Treatment outcome and failure pattern of olfactory neuroblastoma: a clinical analysis of 14 cases and meta-analysis of Japanese cases].
Takenaka Y; Yamamoto M; Cho H; Nakahara S; Yasui T; Yamamoto Y; Nishiike S; Inohara H
Nihon Jibiinkoka Gakkai Kaiho; 2014 May; 117(5):666-72. PubMed ID: 24956744
[TBL] [Abstract][Full Text] [Related]
31. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
32. Choroidal metastasis from olfactory neuroblastoma (esthesioneuroblastoma).
Weissgold DJ; Gragoudas ES; Kent C; Amrein PC; Dickersin GR
Retina; 1999; 19(5):459-62. PubMed ID: 10546948
[No Abstract] [Full Text] [Related]
33. Esthesioneuroblastoma: a meta-analysis and review.
Dulguerov P; Allal AS; Calcaterra TC
Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
[TBL] [Abstract][Full Text] [Related]
34. [Primary experience and discussion on the treatment of esthesioneuroblastoma].
Jiang LJ; Lin TJ; Huang ZQ; Zuo KJ; Zhang Y; Shi JB; Lai YY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 56(7):719-723. PubMed ID: 34344098
[No Abstract] [Full Text] [Related]
35. Pleomorphic olfactory neuroblastoma (esthesioneuroblastoma): histopathological findings and clinical course.
Emerson LL; Layfield LJ; Frame R
Histopathology; 2007 Sep; 51(3):430-2. PubMed ID: 17727493
[No Abstract] [Full Text] [Related]
36. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
[TBL] [Abstract][Full Text] [Related]
37. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
38. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
39. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
40. Esthesioneuroblastoma: the impact of treatment modality.
Chao KS; Kaplan C; Simpson JR; Haughey B; Spector GJ; Sessions DG; Arquette M
Head Neck; 2001 Sep; 23(9):749-57. PubMed ID: 11505485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
